Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
7.27
-0.12 (-1.62%)
At close: Jan 30, 2026, 4:00 PM EST
7.70
+0.43 (5.91%)
Pre-market: Feb 2, 2026, 4:00 AM EST
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $7.25 million as of February 2, 2026. Its market cap has increased by 215.40% in one year.
Market Cap
7.25M
Enterprise Value
-9.02M
1-Year Change
215.40%
Ranking
Category
Stock Price
$7.27
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $131.30M to $7.25M, a decrease of -94.48%. That is a compound annual growth rate of -26.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 6.80M | -22.73% |
| Dec 31, 2025 | 8.80M | 300.00% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -73.77% |
| Dec 30, 2022 | 12.20M | -66.94% |
| Dec 31, 2021 | 36.90M | -75.47% |
| Dec 31, 2020 | 150.40M | 367.08% |
| Dec 31, 2019 | 32.20M | 2.88% |
| Dec 31, 2018 | 31.30M | -70.02% |
| Dec 29, 2017 | 104.40M | 161.00% |
| Dec 30, 2016 | 40.00M | -69.54% |
| Jul 20, 2016 | 131.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuron | 7.97M |
| MetaVia | 7.80M |
| Aptorum Group | 7.71M |
| VivoSim Labs | 7.62M |
| Addex Therapeutics | 7.53M |
| Calidi Biotherapeutics | 7.46M |
| Creative Medical Technology Holdings | 7.06M |
| Mustang Bio | 7.04M |